ADmit Therapeutics
ADmit Therapeutics is a biotechnology company intended to develop a test for early diagnosis of Alzheimer.
2
Funding Rounds
$456.2k
Money raised
Overview
ADmit Therapeutics is a biotechnology company intended to develop a test for early diagnosis of Alzheimer.
-
Websites:
- Business model: B2B
- Headquarters: Barcelona
- Social accounts:
Funding series
Funding Series Analysis
The company ADmit Therapeutics has raised a total of $456.22k in funding over 2 rounds.
Key Insights:
- ADmit Therapeutics Seed round, March 27, 2019: $226.22k
- ADmit Therapeutics March 2019 Pre-Seed Funding Round: $230k
ADmit Therapeutics Seed round, March 27, 2019
$226.22k
ADmit Therapeutics March 2019 Pre-Seed Funding Round
$230k
Industries
ADmit Therapeutics is active in the following industries: